{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:55:38Z","timestamp":1772117738801,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd003038","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T00:00:00Z","timestamp":1372464000000}}],"reference-count":152,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003038.pub2","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T16:51:17Z","timestamp":1372524677000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia"],"prefix":"10.1002","volume":"2016","author":[{"given":"Mical","family":"Paul","sequence":"first","affiliation":[{"name":"Rambam Health Care Campus; Division of Infectious Diseases; Ha-aliya 8 St Haifa Israel 33705"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaakov","family":"Dickstein","sequence":"additional","affiliation":[{"name":"Rambam Health Care Center; Medicine A and Unit of Infectious Diseases; Haifa Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Schlesinger","sequence":"additional","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Grozinsky-Glasberg","sequence":"additional","affiliation":[{"name":"Dept of Medicine, Hadassah-Hebrew University Medical Center; Neuroendocrine Tumors Unit, Endocrinology & Metabolism Service; POB 12000 Jerusalem Israel 91120"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla","family":"Soares-Weiser","sequence":"additional","affiliation":[{"name":"Cochrane; Cochrane Editorial Unit; St Albans House, 57 - 59 Haymarket London UK SW1Y 4QX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Leibovici","sequence":"additional","affiliation":[{"name":"Beilinson Hospital, Rabin Medical Center; Department of Medicine E; 39 Jabotinski Street Petah Tikva Israel 49100"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,6,29]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD003038.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1179\/joc.2001.13.3.281","article-title":"Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey","volume":"13","author":"Agaoglu","year":"2001","journal-title":"Journal of Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0002|cit2","doi-asserted-by":"crossref","unstructured":"Ahmed N Borollosy N Beshlawy A Mahallawy H Haddad A Outpatient single dose ceftriaxone and amikacin vs. imipenem\/cilastatin monotherapy in the empiric treatment of pediatric patients with high risk fever and neutropenia: a randomized, prospective clinical trial Proceedings of Meeting of the American Society of Hematology; Abstract No. 887 2003","DOI":"10.1200\/jco.2004.22.14_suppl.8520"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0003|cit3","doi-asserted-by":"crossref","unstructured":"Ahmed N Borollosy N Beshlawy A Mahallawy H Haddad A Outpatient single dose ceftriaxone and amikacin vs. imipenem\/cilastatin monotherapy in the empiric treatment of pediatric patients with high risk fever aneutropenia: a randomized, prospective clinical trial Proceedings of ASCO Meeting; Abstract No. 8520 2004","DOI":"10.1200\/jco.2004.22.14_suppl.8520"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/pbc.21179","article-title":"Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: a randomized, prospective study","volume":"49","author":"Ahmed","year":"2007","journal-title":"Pediatric Blood Cancer"},{"issue":"1","key":"10.1002\/14651858.CD003038.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0924-8579(99)00096-5","article-title":"Comparison of meropenem with amikacin plus ceftazidime in the empirical treatment of febrile neutropenia: a prospective randomised multicentre trial in patients without previous prophylactic antibiotics. Meropenem Study Group of Turkey","volume":"13","author":"Akova","year":"1999","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"4","key":"10.1002\/14651858.CD003038.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3949\/ccjm.50.4.385","article-title":"Comparative efficacy and toxicity of moxalactam and the combination of nafcillin and tobramycin in febrile granulocytopenic patients","volume":"50","author":"Alanis","year":"1983","journal-title":"Cleveland Clinic Quarterly"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0007|cit7","unstructured":"Antmen B Sasmaz I Tanyeli A Yaman A Kocabas E Bayram I Initial empiric antibiotic treatments in childhood febrile neutropenia: meropenem versus ceftazidime plus amikacin combination Proceedings of the 11th European Congress of Clinical Microbiology and Infectious Diseases Apr 1-4; Istanbul, Turkey 2001 Poster 1087 http:\/\/www.akm.ch\/eccmid2001"},{"issue":"6","key":"10.1002\/14651858.CD003038.pub2-BIB0008|cit8","first-page":"819","article-title":"Randomised study comparing imipenem\/cilastatin to ceftriaxone plus gentamicin in cancer chemotherapy-induced neutropenic fever","volume":"23","author":"Au","year":"1994","journal-title":"Annals of the Academy of Medicine Singapore"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s002770050366","article-title":"Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients","volume":"76","author":"Behre","year":"1998","journal-title":"Annals of Hematology"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/jac\/15.2.239","article-title":"Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin","volume":"15","author":"Bezwoda","year":"1985","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003038.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000048547","article-title":"Comparison of cefepime versus ceftriaxone-amikacin as empirical regimens for the treatment of febrile neutropenia in acute leukemia patients","volume":"47","author":"Borbolla","year":"2001","journal-title":"Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003038.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1128\/AAC.40.5.1108","article-title":"Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer","volume":"40","author":"Cometta","year":"1996","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0013|cit13","first-page":"30b","article-title":"Single agent sulperazone vs. two agent ceftazidime-amikacin in high risk febrile neutropenic patients","volume":"88(10)","author":"Conte","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD003038.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/08880010590896297","article-title":"Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost","volume":"22","author":"Corapcioglu","year":"2005","journal-title":"Pediatric Hematologic Oncology"},{"issue":"4","key":"10.1002\/14651858.CD003038.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/AAC.36.4.801","article-title":"Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients","volume":"36","author":"Cornelissen","year":"1992","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0016|cit16","unstructured":"Cornely OA Reichert D Buchheidt D Maschmeyer G Wilhelm M Chiel X (for the Paul-Erlich-Gesellschaft) Three-armed multicenter randomized study on the empiric treatment of neutropenic fever in a high risk patient population (PEG study III) Proceedings of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy;Abstract L-775 2001"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0017|cit17","first-page":"174","article-title":"Cefepime in the empirical initial treatment of febrile neutropenic cancer patients","volume":"13","author":"Maschmeyer","year":"2004","journal-title":"Chemotherapie Journal"},{"issue":"6","key":"10.1002\/14651858.CD003038.pub2-BIB0018|cit18","first-page":"668","article-title":"Meropenem versus ceftazidime plus amikacin in the treatment of febrile episodes in neutropenic patients: a randomized study","volume":"82","author":"Camara","year":"1997","journal-title":"Haematologica"},{"issue":"8","key":"10.1002\/14651858.CD003038.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1086\/322646","article-title":"A multicenter, double-blind, placebo-controlled trial comparing piperacillin-tazobactam with and without amikacin as empiric therapy for febrile neutropenia","volume":"33","author":"Favero","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0020|cit20","unstructured":"Del Favero A Micozzi A Bucaneve G Martino P Double-blind, randomised, clinical trial comparing monotherapy with piperacillin-tazobactam vs piperacillin-tazobactam plus amikacin as empiric therapy for febrile neutropenic cancer patients Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; Abstract No. 1092 1999"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0021|cit21","first-page":"160, Abstract 6","article-title":"Double blind, randomized, clinical trial comparing monotherapy with piperacillin-tazobactam versus piperacillin-tazobactam plus amikacin as empiric therapy for febrile neutropenic cancer patients.","volume":"8 Suppl","author":"Micozzi","year":"2000","journal-title":"Supportive Care in Cancer"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0022|cit22","unstructured":"De Witte T Antibiotic treatment in patients with haematological malignancies and bone marrow transplantation Perspectives on Therapeutics in Northern Europe 46 London Glaxo 6 7"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/12.suppl_A.93","article-title":"Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients","volume":"12 Suppl A","author":"Pauw","year":"1983","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD003038.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-120-10-199405150-00004","article-title":"Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer: a multicenter randomized trial. The Intercontinental Antimicrobial Study Group","volume":"120","author":"Pauw","year":"1994","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0025|cit25","unstructured":"De Pauw BE Feld R Deresinski S Donnelly JP Lane-Allman E Multicentre, randomised, comparative study of ceftazidime vs piperacillin as empirical therapy for febrile granulocytic patients Proceedings of the Sixth International Symposium of Infections in the Immunocompromised Host. Abstract No 116 1990"},{"issue":"8","key":"10.1002\/14651858.CD003038.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0959-8049(96)00050-0","article-title":"Early identification of neutropenic patients at risk of gram positive bacteraemia and the impact of empirical administration of vancomycin","volume":"32a","author":"Dompeling","year":"1996","journal-title":"European Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0027|cit27","first-page":"89","article-title":"A comparison of imipenem monotherapy versus cefoperazone\/sulbactam plus amikacin combination treatment in febrile neutropenic cancer patients","volume":"11","author":"Dincol","year":"1998","journal-title":"Cancer Journal"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0028|cit28","unstructured":"Doyen C Tepantondele JM Wauters G Michaux JL A randomized therapeutic trial for ceftazidime versus ceftazidime and amikacin in febrile granulopenic patients Proceedings of the 13th International Congress of Chemotherapy Vienna Spitzy KH 1983 26 29"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0029|cit29","first-page":"105","article-title":"Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors","volume":"43","author":"Duzova","year":"2001","journal-title":"The Turkish Journal of Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD003038.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/0011-393X(95)85117-8","article-title":"Comparison of cefoperazone-sulbactam versus piperacillin plus amikacin as empiric therapy in pediatric febrile neutropenic cancer patients","volume":"56","author":"Haddad","year":"1995","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"issue":"5","key":"10.1002\/14651858.CD003038.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3109\/00365549409011817","article-title":"Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure","volume":"26","author":"Erjavec","year":"1994","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"Suppl 1 (Pt 2)","key":"10.1002\/14651858.CD003038.pub2-BIB0032|cit32","first-page":"229b. Abstract","article-title":"Piperacillin\/tazobactam vs. piperacillin\/tazobactam plus amikacin as empiric therapy for fever in neutropenic patients","volume":"10","author":"Esteve","year":"1997","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0033|cit33","unstructured":"Gaytan-Martinez JE Mateos-Garcia E Casanova LJ Fuentes-Allen JL Sanchez-Cortes E Manjarrez-Tellez B Efficacy of empirical therapy with cefepime compared with ceftazidime plus amikacin in febrile neutropenic patients Proceedings of the Annual Meeting of the American Society of Hematology 2002 Abstract No. 3655"},{"issue":"5","key":"10.1002\/14651858.CD003038.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1445-5994.1989.tb00296.x","article-title":"A randomised trial of empirical antibiotic therapy in febrile neutropenic patients with hematological disorders: ceftazidime versus azlocillin plus amikacin","volume":"19","author":"Gibson","year":"1989","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0035|cit35","unstructured":"Glasmacher A Hahn C Molitor E Fixson A Mey U Sauerbruch T A randomized comparison of piperacillin-tazobactam vs. ceftriaxone and gentamicin in 172 severely neutropenic patients with hematologic malignancies Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy 1999 Abstract 1090"},{"issue":"6","key":"10.1002\/14651858.CD003038.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00520-003-0463-7","article-title":"Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison","volume":"11","author":"Gorschluter","year":"2003","journal-title":"Supportive Care in Cancer"},{"issue":"3","key":"10.1002\/14651858.CD003038.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/AAC.24.3.388","article-title":"Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections","volume":"24","author":"Gribble","year":"1983","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD003038.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.0954-6820.1986.tb02759.x","article-title":"Latamoxef versus carbenicillin plus gentamicin or carbenicillin plus mecillinam in leukopenic, febrile patients with solid tumors","volume":"220","author":"Hansen","year":"1986","journal-title":"Acta Med Scand"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0039|cit39","first-page":"Suppl:160. Abst","article-title":"Final results of a prospective randomized trial of bolus meropenem versus infusion meropenem versus ceftazidime\/amikacin as empiric initial therapy for infections and fever of unknown origin in neutropenic patients with hematologic malignancies","volume":"8","author":"Hense","year":"2000","journal-title":"Supportive Care in Cancer"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0040|cit40","first-page":"Suppl 2:S199","article-title":"Prospective randomized trial of bolus meropenem versus infusion meropenem versus ceftazidime\/amikacin as empiric initial therapy for infections and fever of unknown origin in neutropenic patients with hematologic malignancies","volume":"77","author":"Hense","year":"1998","journal-title":"Annals of Hematology"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s005200050184","article-title":"Monotherapy with piperacillin\/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients","volume":"6","author":"Hess","year":"1998","journal-title":"Supportive Care in Cancer"},{"issue":"4","key":"10.1002\/14651858.CD003038.pub2-BIB0042|cit42","first-page":"254","article-title":"Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy","volume":"36","author":"Hung","year":"2003","journal-title":"Journal of Microbiology, Immunology, and Infection"},{"issue":"4","key":"10.1002\/14651858.CD003038.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF01728894","article-title":"Ceftazidime versus ceftazidime plus tobramycin in febrile neutropenic children","volume":"21","author":"Jacobs","year":"1993","journal-title":"Infection"},{"issue":"12","key":"10.1002\/14651858.CD003038.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12094-006-0152-3","article-title":"Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia","volume":"8","author":"Jimeno","year":"2006","journal-title":"Clinical Transplantation and Oncology"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0045|cit45","unstructured":"Jimeno A Arcediano A Gomez C Bezares S Castellano D Paz-Ares L Randomized study of cefepime versus ceftazidime plus amikacin in febrile neutropenic patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) Proceedings of the Annual Meeting of the American Society of Clinical Oncology; Abstract 3387 2003"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0046|cit46","unstructured":"Kiehl MG Bischoff M Basara N Guenzelmann S Fauser AA A prospective randomized trial comparing the efficacy and safety of piperacillin\/tazobactam versus piperacillin\/tazobactam plus netilmicin in the treatment of tebrile neutropenia in allogeneic stem cell recipients Proceedings of the Interscience Conference on Antimicrobial Agents and Chemotherapy 2001"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0195-6701(90)90079-4","article-title":"Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients","volume":"15","author":"Kinsey","year":"1990","journal-title":"Journal of Hospital Infection"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0048|cit48","unstructured":"Kliasova G Savchenko V Lubimova L Mendeleeva L Parovichnikova E Tolkacheva T Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for febrile neutropenic bone marrow transplant patients Proceedings of the 11th European Congress of Clinical Microbiology and Infectious Diseases 2001 http:\/\/www.akm.ch\/eccmid2001\/"},{"issue":"21-22","key":"10.1002\/14651858.CD003038.pub2-BIB0049|cit49","first-page":"417","article-title":"[Assessment of the efficacy of treating infections in hematopoietic proliferative diseases: monotherapy with ceftazidime and tobramycin combined with amoxycillin\/ampicillin]","volume":"45","author":"Koehler","year":"1990","journal-title":"Pol Tyg Lek"},{"issue":"5","key":"10.1002\/14651858.CD003038.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00000421-199410000-00009","article-title":"A randomized prospective study of imipenem-cilastatin with or without amikacin as an empirical antibiotic treatment for febrile neutropenic patients","volume":"17","author":"Kojima","year":"1994","journal-title":"American Journal of Clinicial Oncology"},{"issue":"6","key":"10.1002\/14651858.CD003038.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/jac\/30.6.843","article-title":"A comparative study of imipenem versus piperacillin plus gentamicin in the initial management of febrile neutropenic patients with haematological malignancies","volume":"30","author":"Leyland","year":"1992","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0052|cit52","first-page":"Suppl 1:424","article-title":"Imipenem\/cilastatin versus tobramycin and piperacillin as initial empiric therapy for febrile episodes in neutropenic patients: interim analysis of a prospective randomized comparison","volume":"3","author":"Lieschke","year":"1990","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"Suppl 2:16-22","DOI":"10.1159\/000238734","article-title":"A comparative study of ceftriaxone plus amikacin, ceftazidime plus amikacin and imipenem\/cilastatin in the empiric therapy of febrile granulocytopenic cancer patients","volume":"35","author":"Liu","year":"1989","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0399-077X(05)80140-4","article-title":"Comparative trial of ceftazidime alone, ceftazidime + amikacin and ceftazidime + vancomycin as empiric therapy of febrile cancer patients with induced prolonged neutropenia","volume":"21","author":"Marie","year":"1991","journal-title":"Medicine et Maladies Infectieuses"},{"issue":"37","key":"10.1002\/14651858.CD003038.pub2-BIB0055|cit55","first-page":"1968","article-title":"[Antibiotic therapy protocol using ceftazidime 3g\/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients]. [French]","volume":"17","author":"Marie","year":"1988","journal-title":"Presse Medicale"},{"issue":"Suppl D","key":"10.1002\/14651858.CD003038.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jac\/41.suppl_4.57","article-title":"Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients","volume":"41","author":"Marie","year":"1998","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003038.pub2-BIB0057|cit57","first-page":"275","article-title":"Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial","volume":"2","author":"Pico","year":"1993","journal-title":"Eur J Med"},{"issue":"6","key":"10.1002\/14651858.CD003038.pub2-BIB0058|cit58","first-page":"428","article-title":"A randomized trial comparing imipenem\/cilastatine alone with latamoxef plus tobramycin in febrile neutropenic patients with lung cancer","volume":"21","author":"Matsui","year":"1991","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1002\/14651858.CD003038.pub2-BIB0059|cit59","first-page":"486","article-title":"Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients","volume":"15","author":"Miller","year":"1993","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"Suppl A:347-51","DOI":"10.1093\/jac\/12.suppl_A.347","article-title":"Ceftazidime as a single agent in the management of children with fever and neutropenia","volume":"12","author":"Morgan","year":"1983","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0061|cit61","first-page":"65","article-title":"Imipenem\/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multiclinic study","volume":"52","author":"Norrby","year":"1987","journal-title":"Scandinavian Journal of Infectious Diseases Supplement"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/17843286.1989.11717996","article-title":"Imipenem\/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies","volume":"44","author":"Vandercam","year":"1989","journal-title":"Acta Clinica Belgica"},{"issue":"6","key":"10.1002\/14651858.CD003038.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3109\/00365549009027124","article-title":"Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia","volume":"22","author":"Novakova","year":"1990","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD003038.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01703442","article-title":"Ceftazidime with or without amikacin for the empiric treatment of localized infections in febrile, granulocytopenic patients","volume":"63","author":"Novakova","year":"1991","journal-title":"Annals of Hematology"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3904\/kjim.1999.14.2.15","article-title":"Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients","volume":"14","author":"Ozyilkan","year":"1999","journal-title":"The Korean Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0066|cit66","first-page":"Suppl 5:140. Ab","article-title":"Ceftazidime (CFZ) monotherapy as empirical initial treatment of febrile neutropenia cancer patients (Pts)","volume":"7","author":"Papachristodoulou","year":"1996","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0067|cit67","unstructured":"Pegram SP Muss HB McGall CE Cooper RM White DR Richards F A comparative study of moxalactam vs. ticarcillin and tobramycin in febrile, neutropenic cancer patients Proceedings of the Annual Meetings of the American Society of Clinical Oncology; Abstract No. 255 1982"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0068|cit68","unstructured":"Pegram SP Muss HB McGall CE Cooper RM White DR Richards T A comparative study of moxalactam vs. ticarcillin and tobramycin in febrile, neutropenic cancer patients Proceedings of the Annual Meetings of the American Society of Clinical Oncology; Abstract No. 391 1984"},{"issue":"37","key":"10.1002\/14651858.CD003038.pub2-BIB0069|cit69","first-page":"1960","article-title":"Response to infection in patients with acute leukemia during remission induction treatment: ceftazidime versus cefotaxime + tobramycin","volume":"17","author":"Pellegrin","year":"1988","journal-title":"Presse Med"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0070|cit70","first-page":"141","article-title":"Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison","volume":"42","author":"Pereira","year":"2009","journal-title":"Journal of Microbiology, Immunology and Infection"},{"issue":"3","key":"10.1002\/14651858.CD003038.pub2-BIB0071|cit71","first-page":"312","article-title":"[Imipenem\/cilastatin versus ceftazidime-amikacin in the treatment of febrile neutropenic patients]","volume":"123","author":"Perez","year":"1995","journal-title":"Revista Medica de Chile"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S1413-86702003000200003","article-title":"Evaluation of ticarcillin\/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma.","volume":"7","author":"Petrilli","year":"2003","journal-title":"Brazilian Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD003038.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/AAC.26.6.870","article-title":"Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia","volume":"26","author":"Piccart","year":"1984","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0074|cit74","article-title":"A randomized trial of empiric therapy with moxalactam versus tobramycin plus ticarcillin in febrile, neutropenic patients","volume-title":"Current Choices in Antibiotic Therapy for Febrile Episodes in Neutropenic Patients","author":"Pickard","year":"1983"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0075|cit75","unstructured":"Pickard W Durack D Gallis H A randomized trial of moxalactam versus tobramycin plus ticarcillin in 50 febrile neutropenic patients Proceedings of the 22nd Interscience Conference on Antimicrobial Agents and Chemotherapy; Abstract No. 66 1982"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0076|cit76","unstructured":"Pickard W Gallis HA Durack DT A randomized trial of empiric therapy with moxalactam versus tobramycin plus ticarcillin in febrile neutropenic patients Proceedings of the Second International Symposium in Infections in the Immunocompromised Host 1982"},{"issue":"37","key":"10.1002\/14651858.CD003038.pub2-BIB0077|cit77","first-page":"1954","article-title":"First-line treatment of febrile episodes in leukemia in adults: randomized, multicenter study of ceftazidime in single antibiotic therapy versus a cefotaxime-amikacin combination","volume":"17","author":"Piguet","year":"1988","journal-title":"Presse Med"},{"issue":"1","key":"10.1002\/14651858.CD003038.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/jac\/20.1.109","article-title":"Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effects","volume":"20","author":"Rodjer","year":"1987","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0079|cit79","first-page":"61","article-title":"Cefotaxime vs cephalotin-gentamicin in the first febrile episode of patients having solid tumors and short-term neutropenia","volume":"25","author":"Rodriguez","year":"1995","journal-title":"Acta Cancer"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archinte.1992.00400140037010","article-title":"A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients","volume":"152","author":"Rolston","year":"1992","journal-title":"Archives of Internal Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003038.pub2-BIB0081|cit81","first-page":"1:406a","article-title":"Ceftazidime vs ticalcillin and gentamicin in febrile neutropenic bone marrow transplant patients: a prospective, randomized, double-blind trial","volume":"Abstract 1534","author":"Schuchter","year":"1988","journal-title":"Blood"},{"issue":"3","key":"10.1002\/14651858.CD003038.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0163-4453(90)91019-A","article-title":"Ceftriaxone vs. azlocillin and netilmicin in the treatment of febrile neutropenic children","volume":"20","author":"Smith","year":"1990","journal-title":"The Journal of Infection"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ajh.10236","article-title":"Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study","volume":"71","author":"Tamura","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1086\/383046","article-title":"Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia","volume":"39","author":"Tamura","year":"2004","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-3-642-84899-5_4","article-title":"Initial empiric therapy for fever in neutropenia","volume":"132","author":"Bustamante","year":"1993","journal-title":"Recent Results in Cancer Research"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0087|cit86","doi-asserted-by":"crossref","first-page":"Suppl 7:S1572-8","DOI":"10.1093\/clinids\/11.Supplement_7.S1572","article-title":"Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy versus monotherapy","volume":"11","author":"Wade","year":"1989","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0086|cit87","unstructured":"Wade JC Delin A Finely R Drusano G Thompson B Imipenem versus piperacillin plus amikacin, empiric therapy for febrile neutropenic patients: a double blind trial Proceedings of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy 1987 Abstract No. 1251"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0088|cit88","first-page":"165","article-title":"Cefepime in monotherapy or in combination with amikacine as the empirical treatment of febrile neutropenic patients","volume":"32","author":"Wrzesien-Kus","year":"2001","journal-title":"Acta Haematologica Polonica"},{"issue":"6a","key":"10.1002\/14651858.CD003038.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"83s","DOI":"10.1016\/S0002-9343(96)00113-1","article-title":"Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient","volume":"100","author":"Ramphal","year":"1996","journal-title":"American Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003038.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1128\/AAC.41.8.1704","article-title":"Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients","volume":"41","author":"Yamamura","year":"1997","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/08880010802016847","article-title":"Piperacillin\/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies","volume":"25","author":"Yildirim","year":"2008","journal-title":"Pediatric Hematology and Oncology"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/08880018.2011.557144","article-title":"Piperacillin\/tazobactam monotherapy versus piperacillin\/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia","volume":"28","author":"Zengin","year":"2011","journal-title":"Pediatric Hematology and Oncology"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0093|cit93","unstructured":"Berezin EN Almeida FJ Santos AG Arnoni M Safadi M Peixoto F Asessment of cefepime monotherapy versus combined therapy with ceftriaxone and aminoglycoside in oncologic children and adolescents with febrile neutropenia Proceedings of the 13th European Congress of Clinical Microbiology and Infectious Diseases 2003 UK. Poster 836 http:\/\/www.akm.ch\/eccmid2003\/"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0094|cit94","first-page":"179","article-title":"Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients","volume":"271","author":"Bodey","year":"1976","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"Suppl C:203-9","DOI":"10.1093\/jac\/17.suppl_C.203","article-title":"A prospective randomized study comparing the efficacy of timentin alone or in combination with amikacin in the treatment of febrile neutropenic patients","volume":"17","author":"Bru","year":"1986","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/030089168306900212","article-title":"Empiric therapy of infections in hematologic malignancies: a prospective, randomized trial","volume":"69","author":"Cetto","year":"1983","journal-title":"Tumori"},{"issue":"6","key":"10.1002\/14651858.CD003038.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000239037","article-title":"Randomized comparison of ceftriaxone versus ceftriaxone plus amikacin for the empirical treatment of infections in patients with altered host defense: microbiological and clinical evaluation","volume":"38","author":"D'Antonio","year":"1992","journal-title":"Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD003038.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1128\/AAC.27.4.605","article-title":"Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients","volume":"27","author":"Drusano","year":"1985","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"27","key":"10.1002\/14651858.CD003038.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJM198712313172703","article-title":"Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia","volume":"317","author":"The EORTC International Antimicrobial Therapy Cooperative Group","year":"1987","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"Suppl A:101-10","DOI":"10.1093\/jac\/12.suppl_A.101","article-title":"A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients","volume":"12","author":"Fainstein","year":"1983","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/08880019009033398","article-title":"Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia","volume":"7","author":"Hauer","year":"1990","journal-title":"Pediatric Hematology and Oncology"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0102|cit102","first-page":"Suppl 1 (Pt 1):","article-title":"Piperacillin-tazobactam plus tobramycin is safe and effective therapy in children with febrile neutropenic episodes who are colonised with Enterobacteriaceae expressing extended spectrum \u03b2-lactamases","volume":"10","author":"Hazel","year":"1998","journal-title":"Blood"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"Suppl 1:21-9","DOI":"10.1159\/000238643","article-title":"Comparative study of ceftriaxone monotherapy versus a combination regimen of cefuroxime plus gentamicin for treatment of serious bacterial infections: the efficacy, safety and effect on fecal flora","volume":"34","author":"Hoepelman","year":"1988","journal-title":"Chemotherapy"},{"issue":"8598","key":"10.1002\/14651858.CD003038.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(88)92121-6","article-title":"Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections","volume":"1","author":"Hoepelman","year":"1988","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0105|cit105","first-page":"212","article-title":"Ceftriaxone in the treatment of solid tumour patients with febrile neutropenia","volume":"21","author":"Karthaus","year":"1998","journal-title":"Onkologie"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0106|cit106","unstructured":"Moreno-Sanchez FGR Lazaro RM Tellez E Torres E Monotherapy in patients with neutropenic fever Proceedings of the American Society for Clinical Oncology 1992 Abstract No. 1364"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0107|cit107","first-page":"1194","article-title":"A randomized study of the empirical antibiotic therapy of the infections in neutropenic patients, affected by neoplastic diseases in paediatric age and under a fever attack","volume":"39","author":"Moroni","year":"1987","journal-title":"Giornale di Malattie Infettive e Parassitarie (Journal of Infectious and Parasitic Dieases)"},{"issue":"4","key":"10.1002\/14651858.CD003038.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/jac\/24.4.591","article-title":"Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients","volume":"24","author":"Pegram","year":"1989","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"10.1002\/14651858.CD003038.pub2-BIB0109|cit109","first-page":"173","article-title":"Fever and neutropenia in children: a new therapeutic proposal","volume":"37","author":"Petrilli","year":"1991","journal-title":"Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJM198608283150905","article-title":"A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia","volume":"315","author":"Pizzo","year":"1986","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"Suppl A:89-92","DOI":"10.1093\/jac\/12.suppl_A.89","article-title":"Ceftazidime compared to tobramycin and ticarcillin in immunocompromised haematological patients","volume":"12","author":"Reilly","year":"1983","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0112|cit112","first-page":"674","article-title":"Cefmenoxime or piperacillin plus amikacin: a prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients","volume":"14","author":"Sampi","year":"1987","journal-title":"Gan to Kagaku Ryoho Cancer & Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003038.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1185\/030079905X43631","article-title":"Imipenem\/cilastatin versus piperacillin\/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study.","volume":"21","author":"Sanz","year":"2005","journal-title":"Current Medical Research and Opinion"},{"issue":"12","key":"10.1002\/14651858.CD003038.pub2-BIB0114|cit114","first-page":"1049","article-title":"[Comparison between monotherapy with imipenem\/cilastatin sodium (IPM\/CS) and combinations of IPM\/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders]. [Japanese]","volume":"49","author":"Sawae","year":"1996","journal-title":"Jpn J Antibiot"},{"issue":"1","key":"10.1002\/14651858.CD003038.pub2-BIB0115|cit115","first-page":"79","article-title":"Cefepime or ceftazidime in combination with amikacin as the empirical treatment of febrile neutropenic patients","volume":"31","author":"Wrzesien-Kus","year":"2000","journal-title":"Acta Haematologica Polonica"},{"issue":"23","key":"10.1002\/14651858.CD003038.pub2-BIB0116|cit116","first-page":"1057","article-title":"Evidence of treating febrile neutropenia with netilmicin-ceftazidime","volume":"13","author":"Li","year":"1998","journal-title":"Clinical Assembly"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0117|cit117","unstructured":"Bilgir O Kadikoylu V Bilgir F The comparison of imipenem with piperacillin\/tazobactam and amikacin combination in patients with hematological malignancies in the treatment of febrile neutropenia Proceedings of the 10th Congress of the European Hematology Association 2005 Abstract No. 1021"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"Suppl 4:S559-71","DOI":"10.1093\/clinids\/7.Supplement_4.S559","article-title":"Management of infections caused by gram negative bacilli: the role of antimicrobial combinations","volume":"7","author":"Allan","year":"1985","journal-title":"Reviews of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1086\/430912","article-title":"Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials","volume":"41","author":"Bliziotis","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003038.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/1097-0142(197206)29:6<1697::AID-CNCR2820290638>3.0.CO;2-K","article-title":"Infections in cancer patients: results with gentamicin sulfate therapy","volume":"29","author":"Bodey","year":"1972","journal-title":"Cancer"},{"issue":"8","key":"10.1002\/14651858.CD003038.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","article-title":"Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy","volume":"115","author":"Chow","year":"1991","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003038.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/infdis\/161.3.397","article-title":"From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient: report of a consensus panel","volume":"161","author":"Anonymous","year":"1990","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0124|cit124","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002007","article-title":"Single versus combination intravenous antibiotic therapy for people with cystic fibrosis","author":"Elphick","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/514550","article-title":"Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials","volume":"25","author":"Elting","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD003038.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD003038.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1128\/AAC.25.4.534","article-title":"In vitro synergistic activities of aminoglycosides and new beta lactams against multiresistant Pseudomonas aeruginosa","volume":"25","author":"Giamarellou","year":"1984","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"Suppl 6B:126-37","DOI":"10.1016\/0002-9343(86)90490-0","article-title":"Aminoglycosides plus beta lactams against gram negative organisms: evaluation of in vitro synergy and chemical interactions","volume":"80","author":"Giamarellou","year":"1986","journal-title":"American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003038.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2141.1997.4453255.x","article-title":"A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"99","author":"Hann","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0130|cit130","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"3","key":"10.1002\/14651858.CD003038.pub2-BIB0131|cit131","first-page":"381","article-title":"From the Infectious Diseases Society of America: guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever","volume":"161","author":"Hughes","year":"1990","journal-title":"Journal of Infection"},{"issue":"3","key":"10.1002\/14651858.CD003038.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/513764","article-title":"From the Infectious Diseases Society of America: 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever","volume":"25","author":"Hughes","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD003038.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/infdis\/134.3.271","article-title":"Synergism between amikacin and cefazolin against Klebsiella","volume":"134","author":"Klastersky","year":"1976","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/clinids\/4.2.294","article-title":"Synergistic combinations of antibiotics in gram negative bacillary infections","volume":"4","author":"Klastersky","year":"1982","journal-title":"Review of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/AAC.29.2.263","article-title":"Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients","volume":"29","author":"Klastersky","year":"1986","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD003038.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijantimicag.2010.11.029","article-title":"Clinical implications of -lactam\u2013aminoglycoside synergism: systematic review of randomised trials","volume":"37","author":"Marcus","year":"2011","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"3","key":"10.1002\/14651858.CD003038.pub2-BIB0138|cit138","first-page":"234","article-title":"Development of resistance during antibiotic therapy","volume":"6","author":"Milatovic","year":"1987","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.326.7399.1111","article-title":"Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis","volume":"326","author":"Paul","year":"2003","journal-title":"BMJ"},{"issue":"7441","key":"10.1002\/14651858.CD003038.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/bmj.38028.520995.63","article-title":"Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials","volume":"328","author":"Paul","year":"2004","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jac\/dki448","article-title":"Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials","volume":"57","author":"Paul","year":"2006","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD003038.pub2-BIB0142|cit142","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003344.pub2","article-title":"Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis","author":"Paul","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003038.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/BF00365733","article-title":"Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors","volume":"2","author":"Rossini","year":"1994","journal-title":"Supportive Care in Cancer"},{"issue":"19","key":"10.1002\/14651858.CD003038.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","article-title":"Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia","volume":"284","author":"Schimpff","year":"1971","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0145|cit145","first-page":"Suppl 5C:13-20","article-title":"Empiric antibiotic therapy for granulocytopenic cancer patients","volume":"80","author":"Schimpff","year":"1986","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003038.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD003038.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1200\/JCO.1992.10.2.316","article-title":"Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule","volume":"10","author":"Talcott","year":"1992","journal-title":"Journal of Clinical Oncology"},{"issue":"1b","key":"10.1002\/14651858.CD003038.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1445-5994.2010.02340.x","article-title":"Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee","volume":"41","author":"Tam","year":"2011","journal-title":"Internal Medicine Journal"},{"issue":"4","key":"10.1002\/14651858.CD003038.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijantimicag.2012.12.006","article-title":"\u03b2-Lactam plus aminoglycoside or fluoroquinolone combination versus \u03b2-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis","volume":"41","author":"Vardakas","year":"2013","journal-title":"International Journal of Antimicrobial Agents"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"Suppl 7:S1572-8","DOI":"10.1093\/clinids\/11.Supplement_7.S1572","article-title":"Antibiotic therapy for the febrile granulopenic cancer patient: combination therapy versus monotherapy","volume":"11","author":"Wade","year":"1989","journal-title":"Review of Infectious Diseases"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0151|cit151","first-page":"Suppl 4:S538-44","article-title":"Gram negative bacterial infections: a look at the past, a view of the present, and a glance at the future","volume":"7","author":"Weistein","year":"1985","journal-title":"Review of Infectious Diseases"},{"key":"10.1002\/14651858.CD003038.pub2-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.326.7399.1111","article-title":"Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis","volume":"326","author":"Paul","year":"2003","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003038.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T21:29:08Z","timestamp":1720128548000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003038.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,29]]},"references-count":152,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003038.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718052100.793483132","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718052100.793482710","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718052100.793483042","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,29]]}}}